Capolupo Gabriella Teresa, Galvain Thibaut, Paragò Vito, Tong Cyndy, Mascianà Gianluca, Di Berardino Stefano, Caputo Damiano, La Vaccara Vincenzo, Caricato Marco
Gabriella Teresa Capolupo, Colorectal Surgery Unit, Campus Bio-Medico University of Rome, Rome, Italy.
Health Economics and Market Access, Thibaut Galvain, Johnson & Johnson Medical SAS, Issy Les Moulineaux, France.
Expert Rev Pharmacoecon Outcomes Res. 2022 Jun;22(4):691-697. doi: 10.1080/14737167.2022.1986389. Epub 2021 Dec 1.
Anastomotic leakage (AL) is a severe complication of colorectal surgery. We aimed to quantify inpatient costs and key cost contributors associated with AL in a single Italian center.
Electronic records for adults who had undergone colorectal surgery with anastomosis (January 2015 - December 2016), were retrospectively reviewed. Patients with AL were identified using clinical signs and/or imaging findings and/or intraoperative findings. Available data included patient, clinical, and procedural characteristics, healthcare resource utilization, and inpatient costs. Multivariate models were used to adjust for potential confounders.
AL occurred in 12.3% of patients (N = 317). Mean adjusted inpatient cost was 108% higher (p < 0.001) for patients with AL versus no AL (€14,711; 95% CI: 12,113; 17,866 versus €7,089; 95% CI: 6,623; 7,587). Key cost contributors were ward stay, disposables, operating room, and hospital consultations. Mean losses (reimbursement minus costs) were €2,041/patient with AL. AL extended mean length of stay by 9 days and increased odds of reoperation and ICU stay (all p < 0.001).
Patients with AL place considerable economic and resource burden on healthcare systems and hospital reimbursement rates do not cover treatment costs. This study highlights an unmet need for novel techniques to reduce the burden of AL.
吻合口漏(AL)是结直肠手术的一种严重并发症。我们旨在量化意大利一家单一中心与AL相关的住院费用及主要成本构成因素。
回顾性分析2015年1月至2016年12月期间接受结直肠吻合手术的成年患者的电子记录。通过临床体征和/或影像学检查结果和/或术中发现来确定发生AL的患者。可用数据包括患者、临床和手术特征、医疗资源利用情况以及住院费用。使用多变量模型对潜在混杂因素进行调整。
12.3%的患者(N = 317)发生了AL。发生AL的患者与未发生AL的患者相比,调整后的平均住院费用高出108%(p < 0.001)(14,711欧元;95%可信区间:12,113;17,866欧元 vs 7,089欧元;95%可信区间:6,623;7,587欧元)。主要成本构成因素是病房住院时间、一次性用品、手术室和医院会诊。AL患者的平均损失(报销减去成本)为每位患者2,041欧元。AL使平均住院时间延长了9天,并增加了再次手术和入住重症监护病房的几率(所有p < 0.001)。
发生AL的患者给医疗系统带来了相当大的经济和资源负担,且医院报销率无法覆盖治疗成本。本研究凸显了对降低AL负担的新技术的未满足需求。